Remaining challenges in predicting patient outcomes for diffuse large B-cell lymphoma
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Remaining challenges in predicting patient outcomes for diffuse large B-cell lymphoma
Authors
Keywords
-
Journal
Expert Review of Hematology
Volume -, Issue -, Pages 1-15
Publisher
Informa UK Limited
Online
2019-09-13
DOI
10.1080/17474086.2019.1660159
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Rural and urban patients with diffuse large B-cell and follicular lymphoma experience reduced overall survival: a National Cancer DataBase study
- (2019) Andrew J. Ritter et al. LEUKEMIA & LYMPHOMA
- Liquid Biopsies in Cancer Diagnosis, Monitoring, and Prognosis
- (2019) Gabriele De Rubis et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- The prognostic role of end of treatment FDG-PET-CT in patients with diffuse large B cell lymphoma can be improved by considering it with absolute monocyte count at diagnosis
- (2019) Raffaella Marcheselli et al. LEUKEMIA & LYMPHOMA
- PET-derived tumor metrics predict DLBCL response and progression-free survival
- (2019) Prioty Islam et al. LEUKEMIA & LYMPHOMA
- Dynamic Risk Profiling Using Serial Tumor Biomarkers for Personalized Outcome Prediction
- (2019) David M. Kurtz et al. CELL
- Genetics of diffuse large B-cell lymphoma
- (2018) Laura Pasqualucci et al. BLOOD
- Metabolic heterogeneity on baseline 18FDG-PET/CT scan is a predictor of outcome in primary mediastinal B-cell lymphoma
- (2018) Luca Ceriani et al. BLOOD
- Prognostic value of interim fluorodeoxyglucose and fluorothymidine PET/CT in diffuse large B cell lymphoma
- (2018) Ruimin Wang et al. BRITISH JOURNAL OF RADIOLOGY
- Prognostic Significance of Interim 11C-Methionine PET/CT in Primary Central Nervous System Lymphoma
- (2018) Seo-Yeon Ahn et al. CLINICAL NUCLEAR MEDICINE
- The Immune Landscape of Cancer
- (2018) Vésteinn Thorsson et al. IMMUNITY
- Cancer-Cell-Intrinsic Mechanisms Shaping the Tumor Immune Landscape
- (2018) Max D. Wellenstein et al. IMMUNITY
- Cost Effectiveness of Gene Expression Profile Testing in Community Practice
- (2018) Young Chandler et al. JOURNAL OF CLINICAL ONCOLOGY
- Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology
- (2018) Supriya G. Mohile et al. JOURNAL OF CLINICAL ONCOLOGY
- Diagnosis-to-Treatment Interval Is an Important Clinical Factor in Newly Diagnosed Diffuse Large B-Cell Lymphoma and Has Implication for Bias in Clinical Trials
- (2018) Matthew J. Maurer et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes
- (2018) Bjoern Chapuy et al. NATURE MEDICINE
- Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
- (2018) Roland Schmitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Predicting cancer outcomes from histology and genomics using convolutional networks
- (2018) Pooya Mobadersany et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Therapeutic synergy between tigecycline and venetoclax in a preclinical model of MYC / BCL2 double-hit B cell lymphoma
- (2018) Micol Ravà et al. Science Translational Medicine
- Predictive value of interim positron emission tomography in diffuse large B-cell lymphoma: a systematic review and meta-analysis
- (2018) Coreline N. Burggraaff et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Prevalence and clinical correlates of vulnerable status using the Vulnerable Elders Survey 13 (VES-13) in newly diagnosed adult non-Hodgkin lymphoma (NHL) patients: A LEO cross-sectional analysis.
- (2018) Angelo Fama et al. JOURNAL OF CLINICAL ONCOLOGY
- Genome-wide discovery of somatic regulatory variants in diffuse large B-cell lymphoma
- (2018) Sarah E. Arthur et al. Nature Communications
- Double-Hit Gene Expression Signature Defines a Distinct Subgroup of Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma
- (2018) Daisuke Ennishi et al. JOURNAL OF CLINICAL ONCOLOGY
- Counterpoint: Successes in the Pursuit of Precision Medicine: Biomarkers Take Credit
- (2017) Shumei Kato et al. Journal of the National Comprehensive Cancer Network
- Individual Biomarkers Using Molecular Personalized Medicine Approaches
- (2017) Hans P. Zenner ORL-Journal for Oto-Rhino-Laryngology Head and Neck Surgery
- Direct detection of early-stage cancers using circulating tumor DNA
- (2017) Jillian Phallen et al. Science Translational Medicine
- Predicting clinical outcomes from large scale cancer genomic profiles with deep survival models
- (2017) Safoora Yousefi et al. Scientific Reports
- Vitamin D deficiency and supplementation in patients with aggressive B-cell lymphomas treated with immunochemotherapy
- (2017) Stefan Hohaus et al. Cancer Medicine
- Integrated genomic DNA/RNA profiling of hematologic malignancies in the clinical setting
- (2016) J. He et al. BLOOD
- Evaluating surveillance imaging for diffuse large B-cell lymphoma and Hodgkin lymphoma
- (2016) Jonathon B. Cohen et al. BLOOD
- The 2016 revision of the World Health Organization classification of lymphoid neoplasms
- (2016) S. H. Swerdlow et al. BLOOD
- 2016 US lymphoid malignancy statistics by World Health Organization subtypes
- (2016) Lauren R. Teras et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cell-free DNA Comprises an In Vivo Nucleosome Footprint that Informs Its Tissues-Of-Origin
- (2016) Matthew W. Snyder et al. CELL
- Differential contribution of the mitochondrial translation pathway to the survival of diffuse large B-cell lymphoma subsets
- (2016) Erik Norberg et al. CELL DEATH AND DIFFERENTIATION
- Prognostic value of interim FDG-PET in R-CHOP-treated diffuse large B-cell lymphoma: Systematic review and meta-analysis
- (2016) Hugo J.A. Adams et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Recommendations for the integration of genomics into clinical practice
- (2016) Sarah Bowdin et al. GENETICS IN MEDICINE
- US Intergroup Trial of Response-Adapted Therapy for Stage III to IV Hodgkin Lymphoma Using Early Interim Fluorodeoxyglucose–Positron Emission Tomography Imaging: Southwest Oncology Group S0816
- (2016) Oliver W. Press et al. JOURNAL OF CLINICAL ONCOLOGY
- Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin’s Lymphoma
- (2016) Peter Johnson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA
- (2016) F. Scherer et al. Science Translational Medicine
- The Kyoto Prognostic Index for patients with diffuse large B-cell lymphoma in the rituximab era
- (2016) T Kobayashi et al. Blood Cancer Journal
- Integrating cancer genomic data into electronic health records
- (2016) Jeremy L. Warner et al. Genome Medicine
- Prognostic significance of lymphocyte-to-monocyte ratio in diffuse large B-cell lymphoma: a systematic review and meta-analysis
- (2016) Wen-Kai Xia et al. FEBS Open Bio
- Approach to therapy of diffuse large B-cell lymphoma in the elderly: the International Society of Geriatric Oncology (SIOG) expert position commentary
- (2015) V. A. Morrison et al. ANNALS OF ONCOLOGY
- Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing
- (2015) D. M. Kurtz et al. BLOOD
- Next-Generation Sequencing to Guide Clinical Trials
- (2015) L. L. Siu et al. CLINICAL CANCER RESEARCH
- Next-generation surveillance strategies for patients with lymphoma
- (2015) Jonathon B Cohen et al. Future Oncology
- Prognostic Significance of Diffuse Large B-Cell Lymphoma Cell of Origin Determined by Digital Gene Expression in Formalin-Fixed Paraffin-Embedded Tissue Biopsies
- (2015) David W. Scott et al. JOURNAL OF CLINICAL ONCOLOGY
- Circulating tumour DNA and CT monitoring in patients with untreated diffuse large B-cell lymphoma: a correlative biomarker study
- (2015) Mark Roschewski et al. LANCET ONCOLOGY
- Population-specific prognostic models are needed to stratify outcomes for African-Americans with diffuse large B-cell lymphoma
- (2015) Qiushi Chen et al. LEUKEMIA & LYMPHOMA
- A clinically based prognostic index for diffuse large B-cell lymphoma with a cut-off at 70 years of age significantly improves prognostic stratification: population-based analysis from the Danish Lymphoma Registry
- (2015) Anne O. Gang et al. LEUKEMIA & LYMPHOMA
- Results of a Trial of PET-Directed Therapy for Early-Stage Hodgkin’s Lymphoma
- (2015) John Radford et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vitamin D–dependent induction of cathelicidin in human macrophages results in cytotoxicity against high-grade B cell lymphoma
- (2015) Heiko Bruns et al. Science Translational Medicine
- Diffuse large B-cell lymphoma in the elderly: Impact of prognosis, comorbidities, geriatric assessment, and supportive care on clinical practice. An International Society of Geriatric Oncology (SIOG) Expert Position Paper
- (2015) Vicki A. Morrison et al. Journal of Geriatric Oncology
- Machine learning applications in cancer prognosis and prediction
- (2015) Konstantina Kourou et al. Computational and Structural Biotechnology Journal
- Prognostic factors for diffuse large B-cell lymphoma in the R(X)CHOP era
- (2014) R. Vaidya et al. ANNALS OF ONCOLOGY
- Socioeconomic disparities in mortality after diffuse large B-cell lymphoma in the modern treatment era
- (2014) L. Tao et al. BLOOD
- Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue
- (2014) D. W. Scott et al. BLOOD
- Insurance status is related to diffuse large B-cell lymphoma survival
- (2014) Xuesong Han et al. CANCER
- Evaluating Cell-of-Origin Subtype Methods for Predicting Diffuse Large B-Cell Lymphoma Survival: A Meta-Analysis of Gene Expression Profiling and Immunohistochemistry Algorithms
- (2014) Jay A. Read et al. Clinical Lymphoma Myeloma & Leukemia
- Pretherapy metabolic tumour volume is an independent predictor of outcome in patients with diffuse large B-cell lymphoma
- (2014) Myriam Sasanelli et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Vitamin D Deficiency Impairs Rituximab-Mediated Cellular Cytotoxicity and Outcome of Patients With Diffuse Large B-Cell Lymphoma Treated With but Not Without Rituximab
- (2014) Jörg Thomas Bittenbring et al. JOURNAL OF CLINICAL ONCOLOGY
- Comprehensive geriatric assessment is an essential tool to support treatment decisions in elderly patients with diffuse large B-cell lymphoma: a prospective multicenter evaluation in 173 patients by the Lymphoma Italian Foundation (FIL)
- (2014) Alessandra Tucci et al. LEUKEMIA & LYMPHOMA
- Scoring of MYC protein expression in diffuse large B-cell lymphomas: concordance rate among hematopathologists
- (2014) Amer Z Mahmoud et al. MODERN PATHOLOGY
- Diagnosis of 'double hit' diffuse large B-cell lymphoma and B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and Burkitt lymphoma: when and how, FISH versus IHC
- (2014) S. H. Swerdlow Hematology-American Society of Hematology Education Program
- An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era
- (2013) Z. Zhou et al. BLOOD
- Detection of circulating tumour DNA in patients with aggressive B-cell non-Hodgkin lymphoma
- (2013) Philippe Armand et al. BRITISH JOURNAL OF HAEMATOLOGY
- Poor Concordance among Nine Immunohistochemistry Classifiers of Cell-of-Origin for Diffuse Large B-Cell Lymphoma: Implications for Therapeutic Strategies
- (2013) R. Coutinho et al. CLINICAL CANCER RESEARCH
- The genetic basis of diffuse large B-cell lymphoma
- (2013) Laura Pasqualucci CURRENT OPINION IN HEMATOLOGY
- MYCstatus determination in aggressive B-cell lymphoma: the impact of FISH probe selection
- (2013) Ana M Muñoz-Mármol et al. HISTOPATHOLOGY
- Outcome of frail elderly patients with diffuse large B-cell lymphoma prospectively identified by Comprehensive Geriatric Assessment: results from a study of the Fondazione Italiana Linfomi
- (2013) Francesco Merli et al. LEUKEMIA & LYMPHOMA
- Whole genome expression profiling based on paraffin embedded tissue can be used to classify diffuse large B-cell lymphoma and predict clinical outcome
- (2012) Sharon L. Barrans et al. BRITISH JOURNAL OF HAEMATOLOGY
- Metabolic Signatures Uncover Distinct Targets in Molecular Subsets of Diffuse Large B Cell Lymphoma
- (2012) Pilar Caro et al. CANCER CELL
- Immunohistochemical Double-Hit Score Is a Strong Predictor of Outcome in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
- (2012) Tina Marie Green et al. JOURNAL OF CLINICAL ONCOLOGY
- Concurrent Expression of MYC and BCL2 in Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
- (2012) Nathalie A. Johnson et al. JOURNAL OF CLINICAL ONCOLOGY
- Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study
- (2012) C Visco et al. LEUKEMIA
- Absolute monocyte/lymphocyte count prognostic score is independent of immunohistochemically determined cell of origin in predicting survival in diffuse large B-cell lymphoma
- (2012) Luis F. Porrata et al. LEUKEMIA & LYMPHOMA
- Tailored Therapy in an Unselected Population of 91 Elderly Patients with DLBCL Prospectively Evaluated Using a Simplified CGA
- (2012) A. Olivieri et al. ONCOLOGIST
- Modulated Chemotherapy According to Modified Comprehensive Geriatric Assessment in 100 Consecutive Elderly Patients with Diffuse Large B-Cell Lymphoma
- (2012) M. Spina et al. ONCOLOGIST
- Gene-expression profiling and not immunophenotypic algorithms predicts prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapy
- (2011) G. Gutierrez-Garcia et al. BLOOD
- BCL2 Predicts Survival in Germinal Center B-cell-like Diffuse Large B-cell Lymphoma Treated with CHOP-like Therapy and Rituximab
- (2011) J. Iqbal et al. CLINICAL CANCER RESEARCH
- Role of Functional Imaging in the Management of Lymphoma
- (2011) Bruce D. Cheson JOURNAL OF CLINICAL ONCOLOGY
- The absolute monocyte and lymphocyte prognostic score predicts survival and identifies high-risk patients in diffuse large-B-cell lymphoma
- (2011) R A Wilcox et al. LEUKEMIA
- Cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab versus epirubicin, cyclophosphamide, vinblastine, prednisone and rituximab for the initial treatment of elderly “fit” patients with diffuse large B-cell lymphoma: results from the ANZINTER3 trial of the Intergruppo Italiano Linfomi
- (2011) Francesco Merli et al. LEUKEMIA & LYMPHOMA
- Quantitative image analysis in the assessment of diffuse large B-cell lymphoma
- (2011) Devon S Chabot-Richards et al. MODERN PATHOLOGY
- Racial differences in the presentation and outcomes of diffuse large B-cell lymphoma in the United States
- (2010) Pareen J. Shenoy et al. CANCER
- Genetic stability of tumor microenvironment
- (2010) Matthew Danish et al. CANCER BIOLOGY & THERAPY
- Rearrangement ofMYCIs Associated With Poor Prognosis in Patients With Diffuse Large B-Cell Lymphoma Treated in the Era of Rituximab
- (2010) Sharon Barrans et al. JOURNAL OF CLINICAL ONCOLOGY
- Vitamin D Insufficiency and Prognosis in Non-Hodgkin's Lymphoma
- (2010) Matthew T. Drake et al. JOURNAL OF CLINICAL ONCOLOGY
- Immunohistochemical Methods for Predicting Cell of Origin and Survival in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab
- (2010) Paul N. Meyer et al. JOURNAL OF CLINICAL ONCOLOGY
- A Novel Method of Amplification of FFPET-Derived RNA Enables Accurate Disease Classification with Microarrays
- (2010) P. Mickey Williams et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Maternal Plasma DNA Sequencing Reveals the Genome-Wide Genetic and Mutational Profile of the Fetus
- (2010) Y. M. D. Lo et al. Science Translational Medicine
- MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy
- (2009) K. J. Savage et al. BLOOD
- A comprehensive geriatric assessment is more effective than clinical judgment to identify elderly diffuse large cell lymphoma patients who benefit from aggressive therapy
- (2009) Alessandra Tucci et al. CANCER
- A New Immunostain Algorithm Classifies Diffuse Large B-Cell Lymphoma into Molecular Subtypes with High Accuracy
- (2009) W. W.L. Choi et al. CLINICAL CANCER RESEARCH
- Prognostic impact of activated B-cell focused classification in diffuse large B-cell lymphoma patients treated with R-CHOP
- (2009) Heidi Nyman et al. MODERN PATHOLOGY
- Survival analysis with high-dimensional covariates
- (2009) Daniela M Witten et al. STATISTICAL METHODS IN MEDICAL RESEARCH
- Stromal Gene Signatures in Large-B-Cell Lymphomas
- (2008) G. Lenz et al. NEW ENGLAND JOURNAL OF MEDICINE
- LMO2 Protein Expression Predicts Survival in Patients With Diffuse Large B-Cell Lymphoma Treated With Anthracycline-Based Chemotherapy With and Without Rituximab
- (2007) Yasodha Natkunam et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More